Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk
- 1 May 1998
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 45 (5), 459-462
- https://doi.org/10.1046/j.1365-2125.1998.00710.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Neurodevelopment of Children Exposed in Utero to Antidepressant DrugsNew England Journal of Medicine, 1997
- Selective Serotonin-Reuptake Inhibitors in Pregnancy and LactationHarvard Review of Psychiatry, 1996
- Venlafaxine oxidation in vitro is catalysed by CYP2D6British Journal of Clinical Pharmacology, 1996
- Effect of Exposure to Dothiepin and Northiaden in Breast Milk on Child DevelopmentThe British Journal of Psychiatry, 1995
- Clinical utility of venlafaxine in comparison with other antidepressantsInternational Clinical Psychopharmacology, 1995
- Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United StatesArchives of General Psychiatry, 1994
- Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl MetaboliteThe Journal of Clinical Pharmacology, 1992
- Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics.British Journal of Clinical Pharmacology, 1992
- The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxineChirality, 1992
- Epidemiology of Puerperal PsychosesThe British Journal of Psychiatry, 1987